> Valneva has kicked off a Phase II trial of its Clostridium difficile vaccine. Report
> The European Commission (EC) has put €15.1 million behind a consortium of leading research institutions devoted to advancing development of GlaxoSmithKline's Ebola vaccine candidate. More
> Seattle researchers have discovered a vaccine candidate that they expect to stimulate the production of neutralizing antibodies that defend against infection from a broad spectrum of HIV strains. Release
> The U.S. Patent and Trademark Office has issued key protection for ImmunoCellular Therapeutics' glioblastoma vaccine. Release
And Finally... A mumps outbreak that has so far affected 15 NHL players on 5 teams "could happen anywhere," experts say. More